The programme will be delivered by world leaders at the forefront of immunology and immunotherapy research, each with an internationally renowned research group.ÊÊ

Over the past few years significant advances have been made in our understanding of the molecular and cellular control of immune responses. These discoveries are now being translated into the design and testing of immunotherapeutic interventions for a range of diseases including cancer, autoimmunity and inflammatory disease. This programme is for biomedical or life scientists who wish to extend their knowledge and skills in both immunology and its translation to immunotherapy.

A series of interlinked taught modules cover molecular mechanisms in immune cell differentiation and function, autoimmunity, transplant and tumour immunology, and inflammation. This is complemented by comprehensive coverage of the latest developments in immunotherapy including the use of microbial products in immunomodulation and vaccination, small molecules and biologics, as well as cellular immunotherapy.

Master of Science in Immunology and Immunotherapy programme offered by University of Birmingham aims to allow you to understand the research process, from the fundamental discoveries at the forefront of immunological research, to the application of novel interventional immune-based therapies.

A key part of the MSc programme is the planning, execution and reporting of a piece of independent study leading to submission of a dissertation. This study will be in the form of an extensive laboratory research project carried out in internationally renowned research groups. Each student will be a fully-integrated member of one of the large number of research teams in a wide variety of topics across both immunology and immunotherapy. We also plan to offer some projects within external biotechnology companies.

Employability

Students who complete this MSc programme will have an in-depth up-to-date knowledge of this rapidly advancing field and will have developed the key skills required to either pursue a PhD in these areas or significantly improve their employability for the biomedical, biotechnology and pharmaceutical industrial sectors.